By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Solutia, Inc. 

575 Maryville Center Drive
P.O. Box 66760
St. Louis  Missouri  63166-6760  U.S.A.
Phone: 314-674-1000 Fax:

Solutia Pharmaceutical Services Division
Seamless Development from Bench to Market

Solutia has acquired two leading Swiss companies, CarboGen and Amcis, to provide the Science, Speed and Quality demanded in developing new ethical drugs. Pharmaceutical and biotechnology companies can now globally outsource with Solutia for separate drug development services, or for an entire, seamless process from research through small scale commercial manufacturing.

CarboGen specializes in providing research-based pharmaceutical companies with process research and development, analytical development and the rapid synthesis of API supplies prepared to cGMP. Together, CarboGen's two facilities employ over 200 chemists, of which around 100 have PhDs. CarboGen is a reliable and confidential partner with project management and technology transfer expertise of the highest standards.

AMCIS specializes in contract process development and cGMP manufacturing of key intermediates and bulk APIs for the research based pharmaceutical industry worldwide. With their history, chemical background and scale-up expertise, the 100 staff at Amcis are experts in a broad range of modern organic chemistry, providing reliable and economical processes for commercial scale manufacturing.

With the complementary skills and common systems of CarboGen and Amcis we are able to bring projects to a conclusion in the most efficient manner. Underpinned by our state-of-the-art project management techniques, we are able to drive the synergies within these two businesses. This provides an effective solution which takes time out of the overall project timeline and so allows our customers to achieve their goal of getting more products through the Development Pipeline faster then ever.

Frank Kumli, Marketing Manager
Phone: +41 61 935 53 53
Fax: : +41 61 935 53 88

Last Updated: 08-19-04

Key Statistics

Ownership: Public

Web Site: Solutia, Inc.
Symbol: SOI


Company News
Solutia, Inc. (SOI) Announces Sale of Perkalink┬« Business and Select Primary Accelerators Assets 11/8/2010 10:44:00 AM
Solutia, Inc. (SOI) Opens New Photovoltaic Laboratory 10/12/2010 9:20:45 AM
Solutia, Inc. (SOI) to Present at Credit Suisse Future Energy Conference 6/2/2010 10:31:26 AM
Solutia, Inc. (SOI) Reports Fourth Quarter and Full Year 2009 Results 1/28/2010 8:40:17 AM
Solutia, Inc. (SOI) Reaches Agreement To Sell Pharmaceutical Services Business To Dishman Pharmaceuticals and Chemicals Ltd For $74.5 Million 5/24/2006 3:04:45 PM
Monsanto Company (MON) Welcomes Filing Of Solutia, Inc. (SOI) Reorganization Plan 2/14/2006 10:23:08 AM
Solutia, Inc. (SOI) Announces Price Increase In Adipic Acid 10/19/2005 5:12:17 PM
Solutia, Inc.'s (SOI) U.S. Labor Unions Approve New Collective Bargaining Agreements10/19/2005 5:12:12 PM
Solutia, Inc. (SOI) Enters Field Of Anti-Cancer Drug Conjugates10/19/2005 5:11:35 PM
Solutia, Inc. (SOI) May Sell Off Pharma Business10/19/2005 5:11:19 PM